statistiche ricercatore

Nome	#
Development of novel LP1-based analogues with enhanced delta opioid receptor profile	84
(+)-Pentazocine attenuates SH-SY5Y cell death, oxidative stress and microglial migration induced by conditioned medium from activated microglia	80
The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation.	76
Dual MOR/DOR agonist benzomorphan-based compounds for pain relief	74
Neuroprotective effect of the new sigma receptor ligands cis-(+) and cis-(–)-PPCC	70
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management	70
Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect.	70
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics	69
In vitro and in vivo pharmacological evaluation of LP1, a benzomorphan-based compound	66
Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory Pain	65
Harpagophytum procumbens extract potentiates morphine antinociception in neuropathic rats.	61
In-vitro evaluation of a new benzomorphan-based ligand	60
Synthesis and in vitro opioid receptor studies on benzomorphan-based compounds: LP1, a potent and long-acting antinociceptive	60
Pain management: new long-acting opioid ligands	52
Evaluation of N-substitution in 6,7-benzomorphan compounds	48
Totale	1.005

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	12	0	0	0	0	0	0	0	0	0	0	7	5
2020/2021	64	0	4	10	1	19	1	8	1	3	0	14	3
2021/2022	106	13	15	0	1	15	0	16	4	6	0	3	33
2022/2023	261	19	28	3	52	29	37	0	33	48	1	7	4
2023/2024	133	6	25	5	2	3	37	0	4	0	0	42	9
2024/2025	275	4	80	19	19	60	33	3	14	19	23	1	0
Totale													1.005